← Portfolio Scout

Portfolio company

Atreca

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechConsumer Wellbeing

About

This biotechnology firm developed antibody-based immunotherapies for cancer and malaria, targeting healthcare providers and patients, before initiating liquidation and selling its assets in 2024.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies